ABL Bio Inc.

KOSDAQ:A298380 주식 보고서

시가총액: ₩1.9t

ABL Bio 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Sang Hoon Lee

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기8.8yrs
CEO 소유권27.6%
경영진 평균 재임 기간2.8yrs
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

업데이트 없음

Recent updates

Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?

May 29
Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?

Is ABL Bio (KOSDAQ:298380) Weighed On By Its Debt Load?

Feb 26
Is ABL Bio (KOSDAQ:298380) Weighed On By Its Debt Load?

We Think ABL Bio (KOSDAQ:298380) Can Afford To Drive Business Growth

Mar 31
We Think ABL Bio (KOSDAQ:298380) Can Afford To Drive Business Growth

Should ABL Bio (KOSDAQ:298380) Be Disappointed With Their 33% Profit?

Jan 20
Should ABL Bio (KOSDAQ:298380) Be Disappointed With Their 33% Profit?

Companies Like ABL Bio (KOSDAQ:298380) Are In A Position To Invest In Growth

Dec 16
Companies Like ABL Bio (KOSDAQ:298380) Are In A Position To Invest In Growth

CEO

Sang Hoon Lee

8.8yrs

테뉴어

Dr. Sang Hoon Lee, PH D co-founded PharmAbcine, Inc. in 2008 and serves as its Executive Vice President. Dr. Lee founded ABL Bio Inc. in February 2016 and serves as its President and Chief Executive Office...


리더십 팀

이름위치테뉴어보상소유권
Sang Hoon Lee
Founder8.8yrs데이터 없음27.56%
₩ 511.9b
Jaecheon Lee
Executive VPno data데이터 없음1.55%
₩ 28.9b
Jung Dae Kim
Executive VP & COOno data데이터 없음데이터 없음
You Weon-Kyoo
Executive VP2.8yrs데이터 없음1.43%
₩ 26.6b
Jaeho Jung
Executive VP & Chief of Discoveryno data데이터 없음0%
₩ 0
Jong Hwa Won
Executive VPno data데이터 없음데이터 없음
Eunkyung Kim
Head of Medical & Clinical Development2.8yrs데이터 없음데이터 없음

2.8yrs

평균 재임 기간

경험이 풍부한 관리: A298380 의 관리팀은 경험 ( 2.8 년 평균 재직 기간)으로 간주됩니다.